New device enables improved retinal imaging in periphery

Article

The P200C, a retinal imaging device designed for advanced ocular disease, has been launched by Optos plc.

The P200C, a retinal imaging device designed for advanced ocular disease, has been launched by Optos plc. This device is complementary to the firm's Panoramic200 Scanning Laser Ophthalmoscope (P200), which is used for the early detection of retinal conditions such as glaucoma, diabetic retinopathy and age-related macular degeneration, and for non-eye diseases including diabetes and hypertension.

The P200C is intended to be used in the advanced clinical optometry and ophthalmology markets. Its design improves image accuracy, allowing the capture of images in the mid to very far periphery of the retina by potentially reaching the ora serrata and increasing productivity with its ergonomic patient interface.

Optos plans to market the P200C primarily on a pay-per-patient basis to an estimated 10,000 addressable practice locations in its existing markets of the UK, Germany, the US and Canada.

Recent Videos
David Yorston, FRCS, FRCOphth, discusses his EURETINA keynote lecture
Hoda Shamsnajafabadi, MSc, PhD, presents at the 2024 EURETINA meeting
Timothy L Jackson PhD, MB ChB, FRCOphth, speaks about a combination therapy for VEGF-A/C/D inhibition with sozinibercept and ranibizumab
Carl Awh, MD, FASRS, speaks about the American Society of Retina Specialists (ASRS) at EURETINA
Stefano Mercuri, MD, first author of the winning eposter “Genotype-phenotype correlations in a cohort of genetically determined Retinitis Pigmentosa (RP) Italian patients with Rho gene mutations”
Bahram Bodaghi, MD, PHD, FEBO at the 2024 EURETINA meeting
Enrico Borrelli, MD, FEBO, speaks at EURETINA
Aleksandra Rachitskaya, MD, FASRS, speaks about the Vit-Buckle Society at the 2024 EURETINA Congress.
© 2024 MJH Life Sciences

All rights reserved.